Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion type Assertion NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_head.
- NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion wasGeneratedBy ECO_0000203 NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_provenance.
- NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion wasDerivedFrom befree-20150227 NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_provenance.
- NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion SIO_000772 25087097 NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_provenance.
- NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion evidence source_evidence_literature NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_provenance.
- NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_assertion description "[First-line gefitinib therapy is effective and feasible for elderly patients harboring EGFR mutation, and improves disease-related symptoms, especially pulmonary symptoms like shortness of breath and cough.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368582.RADdrvJ8ZU_X18wuPljayw9S4ZYmP-ay5tCGwH1UVARKc130_provenance.